Peter Colabuono
InvestorManaging Director at Decheng Capital · Board director at SunnyBay BioTech, Inc.
Menlo Park, California, United States
About
Peter Colabuono is a Managing Director at Decheng Capital, where he has worked since October 2016, contributing finance, investment, transaction, operational, and drug development experience. Before Decheng, he held operational roles and worked as an Associate at Frazier Healthcare Ventures, where he led the investment and formation of Silvergate Pharmaceuticals, and earlier worked in the healthcare investment banking groups at Morgan Stanley and Cowen. He holds a B.A. in Molecular Biology and Biochemistry from Dartmouth College and is named as an inventor and author on patents and journal articles.
Contact· self-published, not guessed
Invests in
Biotech
Board director at SunnyBay BioTech, Inc.
Intro paths
In turn, Peter can intro founders to SunnyBay BioTech, Inc.'s investors below.
SunnyBay BioTech, Inc.'s investors · 1
Experience
- Decheng CapitalManaging Directorcurrent2016 — presentMenlo Park, CA
- Ironwood PharmaceuticalsSenior Director, Business Development2015 — 2016Cambridge, MA
- Aquilo PartnersVice President2014 — 2015Cambridge, MA
- Silvergate PharmaceuticalsVice President of Managed Care & Corporate Development2011 — 2014
- Frazier Healthcare VenturesAssociate2008 — 2011
- Morgan StanleyAnalyst2006 — 2007
- Cowen & CompanyAnalyst2005 — 2006
Skills & more
+8 more
Start-upsCorporate FinanceCompetitive AnalysisBusiness DevelopmentEntrepreneurshipEmerging MarketsMedical DevicesM&A experienceFrom Peter's professional profile.
Investments
Led
Silvergate Pharmaceuticals
Board seats
Aadi BioscienceAriagenCheckmate PharmaceuticalsConjugateBioFirefly BiologicsSolve TherapeuticsVelos Biopharma
Per the firm's website.
Colleagues at Decheng Capital
Frequently asked questions
- Who is Peter Colabuono?
- Peter Colabuono is a Managing Director at Decheng Capital, where he has worked since October 2016, contributing finance, investment, transaction, operational, and drug development experience. Before Decheng, he held operational roles and worked as an Associate at Frazier Healthcare Ventures, where he led the investment and formation of Silvergate Pharmaceuticals, and earlier worked in the healthcare investment banking groups at Morgan Stanley and Cowen. He holds a B.A. in Molecular Biology and Biochemistry from Dartmouth College and is named as an inventor and author on patents and journal articles.
- Where does Peter Colabuono work?
- Peter Colabuono is Managing Director at Decheng Capital and Board director at SunnyBay BioTech, Inc..
- What does Peter Colabuono invest in?
- Peter Colabuono invests in Biotech.
- What boards does Peter Colabuono sit on?
- Peter Colabuono holds tracked board seats at Aadi Bioscience, Ariagen, Checkmate Pharmaceuticals, ConjugateBio, Firefly Biologics, Solve Therapeutics, Velos Biopharma.
- What companies has Peter Colabuono invested in?
- Investments tracked here include Silvergate Pharmaceuticals.
- Where did Peter Colabuono go to school?
- Peter Colabuono studied at Dartmouth College (Bachelor of Arts (B.A.), Molecular Biology & Biochemistry).
- Does Peter Colabuono lead rounds?
- Yes — Peter Colabuono has led 1 tracked investment.
Same school
Also attended Dartmouth College409
+ 403 more
Shared employers
Also worked at Ironwood Pharmaceuticals3
Also worked at Aquilo Partners1
Also worked at Morgan Stanley1,001
+ 995 more
Also worked at Cowen & Company53
+ 47 more